Head-to-Head

Moderna, Inc. Common Stock vs. Replimune Group, Inc.

MRNA

Moderna, Inc. Common Stock

$221.72 -0.47%

VS REPL

Replimune Group, Inc.

$18.09 +2.75%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

MRNAREPL
Market Cap $88.52 billion $1.67 billion

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

MRNAREPL
Short Interest 0.01% 0.03%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: MRNA overview, MRNA financials, REPL overview, REPL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.